Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report.

Saved in:
Bibliographic Details
Title: Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report.
Authors: Puleo, Maria1,2 (AUTHOR), Pafumi, Sarah1,2 (AUTHOR), Di Pietro, Martina3 (AUTHOR), Ricciardi, Giuseppina Rosaria Rita1,3 (AUTHOR), Sanò, Maria Vita1,2 (AUTHOR) mariavita.sano@humanitascatania.it
Source: Reports (MDPI AG). Sep2025, Vol. 8 Issue 3, p126. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2571841X
DOI:10.3390/reports8030126